Page last updated: 2024-10-30

loperamide and Pancreatic Neoplasms

loperamide has been researched along with Pancreatic Neoplasms in 1 studies

Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamashiro, Y1
Yamamoto, K1
Sato, M1

Other Studies

1 other study available for loperamide and Pancreatic Neoplasms

ArticleYear
Loperamide therapy in a child with vipoma-associated diarrhoea.
    Lancet (London, England), 1982, Jun-19, Volume: 1, Issue:8286

    Topics: Adenoma, Islet Cell; Diarrhea, Infantile; Female; Humans; Infant; Loperamide; Pancreatic Neoplasms;

1982